UnitedHealth Stock Loses Gains After Strong Q2 Earnings

UnitedHealth Group (UNH) reported adjusted earnings of $6.38 per share in July, roughly 30% ahead of the $4.92 the Street modeled, and raised full-year guidance.

The shares spiked toward a 52-week high on the print, but then spent six weeks handing all of it back, closing at $392.95 on August 28 and erasing the entire post-earnings gain.

Erste Group reportedly cut UNH to Hold from Buy on August 26, while Bernstein's Lance Wilkes kept his Buy and raised his target after a Centers for Medicare & Medicaid Services rate notice for 2027.

The company's revenue landed at $112.03 billion, operating earnings of $8 billion grew 55% year over year, and the medical care ratio improved to 86.7% from 89.4% a year earlier.